Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial
| Image |  |
|---|---|
| Description | article by Pierre Théroux et al published 4 May 2005 in European Heart Journal |
| Author/s | |
| Publication date | May 4, 2005 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |